Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus - Related Studies

Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus (FumaCLE)

This study is currently recruiting participants.

Verified July 2011 by University Hospital Muenster

Study NCT01352988 Information provided by University Hospital Muenster

First Received on April 29, 2011. Last Updated on March 1, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Fumaric acid esters

Additional drug interventions recognized in this trial

Dimethyl fumarate

More general drug interventions related to this trial

Sponsors listed in this trial